Research article · 19 Aug 2025
Conference abstractPublished 2 Oct 2017
Gene-specific enhancement of protein synthesis by targeting 5’UTRs -A novel oligonucleotide-based strategy for translational control of selected tumor suppressors
DNAi - The Center of Genetic Information, Poland; University of Warsaw, Poland; Medical University of Warsaw, Poland
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: The frequently reported lack of correlation between various mRNA and protein levels in cancers suggests that translational control can be an important target for new therapeutics regulating mechanisms of protein biosynthesis. Naturally occurring microRNAs and synthetic siRNAs are the most recognized regulatory molecules acting via RNA interference. Surprisingly, recent studies have shown that the interfering RNAs may also activate gene transcription via the newly discovered phenomenon of small RNA-induced gene activation (RNAa), triggered by promoter-specific small activating RNAs (saRNAs). Findings: Here we show that oligonucleotide-based trans-acting factors termed dGoligos (dGs), which were designed by our dGenhancer calculator, can also specifically enhance gene expression at the level of protein translation by acting at sequencespecific targets within mRNA 5âÂ?Â?-untranslated regions (5âÂ?Â?UTRs) of THRB suppressor. The in vitro translation efficiency of reporter constructs containing alternative TRÃ?²1 5âÂ?Â?UTRs was increased by up to 55.8-fold following exposure to specific dGs. Complementary in vivo study showed that dGs can enhance TRÃ?²1-5âÂ?Â?UTR-mediated translation up to 4.8-fold. This method was successfully applied to enhance translation of another CDKN2A suppressor. Moreover, we show that the most folded 5âÂ?Â?UTR has higher translational regulatory potential when compared to the weakly folded TRÃ?²1 variant suggesting that the strategy may be especially applied to enhance protein synthesis from translationally non-active or less-active transcripts containing long complex 5âÂ?Â?UTRs. dGs can serve as molecular switches to translationally active conformation of folded 5'UTRs leading to efficient translation of target mRNAs. Significance: This study represent the first strategy for gene-specific translation enhancement using selective trans-acting factors designed to target specific 5âÂ?Â?UTR cis-acting elements. This developmental strategy may complement other available methods for gene expression regulation including gene silencing and may find its use in enhancement of genes frequently silenced in cancers and other genetic disorders, especially at the level of translational control.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Drug Designing: Open Access.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDrug Designing: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Adam Master”
- BylineArticles whose byline prints “Anna Wojcicka”
- BylineArticles whose byline prints “Alicja Nauman”
